131 related articles for article (PubMed ID: 36875898)
1. Impact of Age at Diagnosis on Cardiotoxicity in High-Grade Osteosarcoma and Ewing Sarcoma Patients.
Heemelaar JC; Speetjens FM; Al Jaff AAM; Evenhuis RE; Polomski EAS; Mertens BJA; Jukema JW; Gelderblom H; van de Sande MAJ; Antoni ML
JACC CardioOncol; 2023 Feb; 5(1):117-127. PubMed ID: 36875898
[TBL] [Abstract][Full Text] [Related]
2. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
Skubitz KM; Blaes AH; Konety SH; Francis GS
Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
[TBL] [Abstract][Full Text] [Related]
3. Sex Differences in the Development of Anthracycline-Associated Heart Failure.
Diaz ANR; Hurtado GP; Manzano AAA; Keyes MJ; Turissini C; Choudhary A; Curtin C; Dommaraju S; Warack S; Strom JB; Asnani A
J Card Fail; 2023 Nov; ():. PubMed ID: 37951494
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.
Henry ML; Niu J; Zhang N; Giordano SH; Chavez-MacGregor M
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1084-1093. PubMed ID: 30092967
[TBL] [Abstract][Full Text] [Related]
6. Impact of locus of care on outcomes in adolescents and young adults with osteosarcoma and Ewing sarcoma treated at pediatric versus adult cancer centers: An IMPACT cohort study.
Mortazavi M; Baxter NN; Gupta S; Gupta AA; Lau C; Nagamuthu C; Nathan PC
Pediatr Blood Cancer; 2022 Apr; 69(4):e29458. PubMed ID: 35029312
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification and pattern of cardiotoxicity in pediatric Ewing sarcoma.
Moussa E; Zamzam M; Kamel A; Salah Z; Attia I; Gaber L; Soliman R; Ezzat S
J Egypt Natl Canc Inst; 2017 Mar; 29(1):53-56. PubMed ID: 28258912
[TBL] [Abstract][Full Text] [Related]
8. Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life.
Reimer Jensen AM; Zierath R; Claggett B; Skali H; Solomon SD; Matsushita K; Konety S; Butler K; Kitzman DW; Biering-Sørensen T; Shah AM
JAMA Cardiol; 2021 May; 6(5):509-520. PubMed ID: 33729428
[TBL] [Abstract][Full Text] [Related]
9. Is There a Cardiotoxicity Associated With Metallic Head Hip Prostheses? A Cohort Study in the French National Health Insurance Databases.
Lassalle M; Colas S; Rudnichi A; Zureik M; Dray-Spira R
Clin Orthop Relat Res; 2018 Jul; 476(7):1441-1451. PubMed ID: 29698302
[TBL] [Abstract][Full Text] [Related]
10. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
[TBL] [Abstract][Full Text] [Related]
11. Bone sarcoma incidence in the Netherlands.
Goedhart LM; Ho VKY; Dijkstra PDS; Schreuder HWB; Schaap GR; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Suurmeijer AJH; Jutte PC
Cancer Epidemiol; 2019 Jun; 60():31-38. PubMed ID: 30903831
[TBL] [Abstract][Full Text] [Related]
12. Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Italiano A; Mir O; Mathoulin-Pelissier S; Penel N; Piperno-Neumann S; Bompas E; Chevreau C; Duffaud F; Entz-Werlé N; Saada E; Ray-Coquard I; Lervat C; Gaspar N; Marec-Berard P; Pacquement H; Wright J; Toulmonde M; Bessede A; Crombe A; Kind M; Bellera C; Blay JY
Lancet Oncol; 2020 Mar; 21(3):446-455. PubMed ID: 32078813
[TBL] [Abstract][Full Text] [Related]
13. The association between heart failure and incident cancer in women: an analysis of the Women's Health Initiative.
Leedy DJ; Reding KW; Vasbinder AL; Anderson GL; Barac A; Wactawski-Wende J; Shadyab AH; Eaton CB; Levy WC; Qi L; Cheng RK
Eur J Heart Fail; 2021 Oct; 23(10):1712-1721. PubMed ID: 33932263
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
15. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study.
Jacobse JN; Schaapveld M; Boekel NB; Hooning MJ; Jager A; Baaijens MHA; Hauptmann M; Russell NS; Rutgers EJT; Aleman BMP; Sonke GS; van Leeuwen FE
Breast Cancer Res Treat; 2021 Jan; 185(1):205-214. PubMed ID: 32964358
[TBL] [Abstract][Full Text] [Related]
16. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
17. Cumulative Burden of Chronic Health Conditions in Adult Survivors of Osteosarcoma and Ewing Sarcoma: A Report from the St. Jude Lifetime Cohort Study.
Bishop MW; Ness KK; Li C; Liu W; Srivastava DK; Chemaitilly W; Krull KR; Green DM; Pappo AS; Robison LL; Hudson MM; Mulrooney DA
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1627-1638. PubMed ID: 32499311
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
Marina NM; Liu Q; Donaldson SS; Sklar CA; Armstrong GT; Oeffinger KC; Leisenring WM; Ginsberg JP; Henderson TO; Neglia JP; Stovall MA; Yasui Y; Randall RL; Geller DS; Robison LL; Ness KK
Cancer; 2017 Jul; 123(13):2551-2560. PubMed ID: 28222219
[TBL] [Abstract][Full Text] [Related]
19. Bone sarcoma follow-up; a nationwide analysis of oncological events after initial treatment.
Goedhart LM; Ho VKY; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Stevens M; Jutte PC
J Bone Oncol; 2023 Feb; 38():100466. PubMed ID: 36578650
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.
Armenian SH; Hudson MM; Chen MH; Colan SD; Lindenfeld L; Mills G; Siyahian A; Gelehrter S; Dang H; Hein W; Green DM; Robison LL; Wong FL; Douglas PS; Bhatia S
BMC Cardiovasc Disord; 2016 Oct; 16(1):187. PubMed ID: 27716152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
